on behalf of the Asia hepatitis lamivudine study group. Extendet lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy. - Leung,NWY.; Lai,CL.; Chang,TT. (Hepatology, 2001)